Metropolis Healthcare shares jumped more than 3% in early trade after the diagnostics company reported a strong set of earnings for the September quarter. As of 9:20 AM, the shares were trading 2.65% higher at Rs 2,084.60.
The company’s consolidated revenue grew 22.7% year-on-year to ₹429 crore, compared to ₹350 crore in the same period last year, driven by robust growth in non-COVID business and higher patient volumes.
EBITDA rose 20.4% to ₹108 crore from ₹89.9 crore, while margins remained healthy at 25.2% versus 25.7% a year ago. Net profit increased 13.2% to ₹52.7 crore against ₹46.5 crore in the corresponding quarter last year.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information.
